Výsledky vyhledávání - "Maureen Clement"

Assessing the Effect of Quality-Improvement Strategies for Organization of Care in Type 2 Diabetes Outcomes in Adults: Aim-Strait

Autor: Jean-Francois Richard, Olaf Heisel, Diana Sherifali, Harpreet S. Bajaj, Alice Y.Y. Cheng, Maureen Clement, Paul Keown, Doron Eisen

Publikováno v: Canadian journal of diabetes. 45(4)

To observe the effect of an organization-of-care improvement process on the achievement of therapeutic goals for people with type 2 diabetes mellitus (T2DM).This single-arm cohort study analyzed the electronic medical records of patients with T2DM in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54f3172c25bd9a9d334996c960660e24
https://pubmed.ncbi.nlm.nih.gov/33223422

Zobrazit plný text záznamu

CANadian CAnagliflozin REgistry: Effectiveness and safety of canagliflozin in the treatment of type 2 diabetes mellitus in Canadian clinical practice

Autor: Luis Noronha, Fernando Camacho, Natasha Georgijev, Vincent Woo, Jennifer B. Rose, Maureen Clement, Wally Rapattoni, Matthew D. Culham, Shana Traina, Alan Bell, Michael A. Tsoukas, Harpreet S. Bajaj

Publikováno v: Diabetes, Obesity & Metabolism

Aim There is limited information concerning the effects of canagliflozin (CANA), a sodium-glucose co-transporter 2 inhibitor (SGLT2i) in a real-world clinical setting in Canada. CanCARE is a 12-month, prospective, observational analysis to demonstrat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6d2922cc28020f6568870e9b5574a2b
http://europepmc.org/articles/PMC6667918

Zobrazit plný text záznamu

Type 2 Diabetes, Hypoglycemia, and Basal Insulins: Ongoing Challenges

Autor: Maureen Clement, Ian Blumer

Publikováno v: Clinical Therapeutics. 39:S1-S11

Hypoglycemia in people with insulin-treated type 2 diabetes can be a limiting factor for management and a barrier to optimizing glycemic control. Even mild episodes of hypoglycemia can affect an individual's quality of life, and fear of hypoglycemia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65313c05d7ce99e2b572739be79190dc
https://doi.org/10.1016/j.clinthera.2016.09.020

Zobrazit plný text záznamu

CANadian CAnagliflozin REgistry: Patient-Reported Outcomes of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Canadian Clinical Practice

Autor: Vincent Woo, Jennifer B. Rose, Alan Bell, Fernando Camacho, Maureen Clement, Delna Sorabji, Michael A. Tsoukas, Natasha Georgijev, Shana Traina, Harpreet S. Bajaj, Luis Noronha

Publikováno v: Canadian journal of diabetes. 43(7)

To describe patient-reported outcomes (PROs) after initiation of treatment with canagliflozin (CANA) for type 2 diabetes mellitus (T2DM) in a real-world Canadian setting.CANadian CAnagliflozin REgistry (CanCARE) is a prospective, observational, singl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e627cf4a2cc1d4a2e8757a6c1056fc7
https://pubmed.ncbi.nlm.nih.gov/31133438

Zobrazit plný text záznamu

CANadian CAnagliflozin REgistry (CanCARE)—A Prospective, Observational Assessment of Canagliflozin (CANA) Treatment in Type 2 Diabetes Mellitus (T2DM)—Twelve-Month Results

Autor: Vincent Woo, Alan Bell, Harpreet S. Bajaj, Fernando Camacho, Jennifer B. Rose, Maureen Clement, Wally Rapattoni, Natasha Georgijev

Publikováno v: Diabetes. 67

CanCARE is a Canadian multicenter, prospective cohort study that enrolled SGLT2 inhibitor-naïve adult patients with T2DM, with A1c ≥7% on a stable anti-hyperglycemic agent (AHA) regimen at baseline and eGFR ≥ 60 mL/min/1.73m2, who were initiated

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e2d266727fe5dfa740cdc93fe6bc54fc
https://doi.org/10.2337/db18-1184-p

Zobrazit plný text záznamu

Relationship between Weight Change Patterns and Health Satisfaction in the CANadian Canagliflozin Registry (CanCARE) Study

Autor: Delna Sorabji, Vincent Woo, Harpreet S. Bajaj, Fernando Camacho, Jennifer B. Rose, Natasha Georgijev, Shana Traina, Maureen Clement, Alan Bell

Publikováno v: Diabetes. 67

Patient health satisfaction is associated with positive health behaviors and is considered important for optimal management of type 2 diabetes mellitus (T2DM). In previously reported randomized clinical trials (RCTs) of canagliflozin (CANA), CANA red

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5023cb465e91447b2d5aaf89b4756633
https://doi.org/10.2337/db18-821-p

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání